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Abstract
Background: The Healthy Lifestyles Programme (HeLP) trial is being conducted to determine whether a novel
school-based intervention is effective and cost-effective in preventing obesity in 9–10 year-old children. This
article describes the detailed statistical analysis plan for the HeLP trial, including an amendment (and rationale for
amendment) made to originally planned sensitivity analyses.
Methods and design: The HeLP trial is a definitive, pragmatic, superiority, cluster randomised controlled trial with
two parallel groups and blinded outcome assessment. This update article describes in detail (1) the primary and
secondary outcomes, (2) the statistical analysis principles (including which children will be included in each analysis,
how the clustered nature of the study design will be accounted for, which covariates will be included in each
analysis, how the results will be presented), (3) planned sensitivity analyses, planned subgroup analyses and
planned adherence-adjusted analyses for the primary outcome, (4) planned analyses for the secondary outcomes
and (e) planned longitudinal analyses.
Trial registration: International Standard Randomised Controlled Trial Number (ISRCTN) register: ISRCTN15811706.
Registered on 1 May 2012.
Keywords: Statistical analysis plan, School-based, Cluster randomised controlled trial, Childhood obesity
Background
The World Health Organization regards childhood
obesity as one of the most serious global public health
challenges for the 21st century. Data from the UK
National Child Measurement Programme show that a
quarter of children enter primary school overweight or
obese and that one third of 10–11-year olds are over-
weight or obese [1]. The Health Lifestyles Programme
(HeLP) was developed with schools, children and their
families and aims to motivate and support children and
their families in making healthy diet and activity choices
[2–5]. The study protocol for the cluster randomised
controlled trial of HeLP was published in Trials in 2013
and included a brief overview of the statistical analyses
[6]. The International Conference on Harmonisation
(ICH) guidelines state that primary statistical analyses
should be prespecified, to protect from data-driven
choice of analyses and selective reporting of outcomes
[7]. This update article presents the detailed statistical
analysis plan, which was written and approved by the Trial
Steering Committee (TSC) in October 2015 (i.e. prior to
final database lock), together with agreed amendment to
the plan, with the analyses following the updated guidance
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Consolidated Standards of Reporting Trials (CONSORT)
extension statement for cluster randomised trials [8].
Methods and design
Brief study overview
This trial of HeLP is a definitive, pragmatic, superiority,
cluster randomised controlled trial with two parallel
groups and blinded assessment. The study population is
9–10-year old school children attending state primary
schools in South West England. All state primary
schools with a single year-5 class with more than 20 pu-
pils were eligible, and all pupils from recruited schools
were invited to participate.
A total of 32 schools were recruited in 2012 and ran-
domised in a 1:1 ratio to receive either HeLP (interven-
tion) or continue as usual (control), stratified by (1) the
proportion of children eligible for free school meals
(<19%, ≥19%; which represented the national average of
pupils eligible for free school meals at the start of the
trial) and (2) number of year-5 classes (one year-5 class,
more than one year-5 class). For practical reasons half
the schools commenced the study in 2012 (cohort 1)
and the other half in 2013 (cohort 2), with equal num-
bers of control and intervention schools in both cohorts,
to facilitate trial delivery. Across the 32 schools, 1324
children were recruited: children and their parents had
the option to opt out of the trial before baseline mea-
sures were collected. Outcomes were recorded at base-
line (before schools were allocated to intervention or
control), 12, 18 and 24 months post baseline. Full details
of the trial background and rationale, design and sample
size calculation have been previously reported [6].
Intervention
The Healthy Lifestyles Programme is a primary school-
based intervention designed to prevent overweight and
obesity in children [6]. The intervention has been
developed using intervention mapping (with extensive
stakeholder involvement) and has been guided by the In-
formation, Motivation, and Behavioural Skills model [9].
HeLP runs over three school terms and includes creating
a receptive environment, drama activities, goal setting
and reinforcement activities. Full details of the interven-
tion and logic model are published elsewhere [2, 5].
Having successfully completed an exploratory trial with
cluster randomisation [3, 4], funding was secured from
the National Institute for Health Research (NIHR) Public
Health Research programme in March 2012 to run a
definitive trial of HeLP.
Trial objectives
The objectives of this cluster randomised controlled trial
are to: (1) assess the effectiveness of HeLP, in children
aged 9–10 years, in terms of Body Mass Index (BMI)
Standard Deviation Score (SDS) (i.e. at 24 months post
baseline), (2) assess the effectiveness of HeLP with
respect to a range of secondary outcomes, including
further anthropometric measures and classification of
weight status at 18 and 24 months and physical activity
and food intake at 18 months post baseline, (3) estimate
the costs of delivering HeLP and its cost-effectiveness
and (4) to conduct a mixed-methods process evaluation
and mediational analysis to explore the way the
programme worked (that is, how it was delivered, taken
up and experienced, and what the behavioural mediators
of change are). This article focuses on the analyses
planned to address (1) and (2).
Flow of schools and children
The flow of schools and children through the trial will
be reported in accordance with the CONSORT exten-
sion statement for cluster trials (Fig. 1) [8]. The flow dia-
gram will include the number of eligible and recruited
schools, number of eligible and recruited children and
then, by allocated group, the number of children who
continued through the trial, the number withdrawing at
each time point, the number lost to follow-up at each
time point and the numbers included in the analysis.
Withdrawals
In schools allocated to the intervention group, children
or their parent/carer could choose to opt out from par-
ticipating in the collection of outcome measures, whilst
participating in the intervention if this was appropriate.
Children who discontinue completing the data collection
prior to the end of the trial period were withdrawn but
will remain in the full analysis population unless they re-
quest otherwise. Reasons for withdrawal are documented
wherever possible.
Integrity of data
All outcome data are independently double entered. All
inconsistencies between data entries are investigated and
any discrepancies discussed with, and resolved by, the
trial manager. The integrity of the data has been moni-
tored regularly, with scrutiny of data files for omissions
and errors. Range and sense checks will be performed
on all variables prior to commencing statistical analyses.
Outcomes
Primary outcome
The primary outcome is BMI SDS at 24 months post
baseline, measured on the whole cohort of recruited
children. BMI SDS indicates how many units (of the
standard deviation) a child’s BMI is above or below the
average BMI value for their age group and gender. The
trial is powered to detect a difference between allocated
trial groups in the BMI SDS of 0.25 units at 24 months,
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with 90% power and a two-sided type 1 error rate of
0.05, assuming the standard deviation of BMI SDS is 1.3
units, the correlation between baseline and 24 months
BMI SDS is 0.8 and an intraclass correlation coefficient
(ICC) of 0.02 [6]. BMI for each child is calculated from
weight and height measurements collected at baseline,
18 and 24 months by assessors blinded to allocated
group. Height is measured using a SECA stadiometer
Fig. 1 Flow of schools and children through the HeLP trial
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(Hamburg, Germany), recorded to an accuracy of 1 mm.
Weight is measured using the Tanita Body Composition
Analyser SC-330 (Tanita UK Ltd., Middlesex, UK) and
recorded to within 0.1 kg and children are asked to take
off their shoes and socks [6]. BMI SDS is then derived
by converting BMI to centiles using the LMS method
and the 1990 BMI UK age and sex thresholds [10, 11].
Secondary outcomes
1. Anthropometric measures at 18 and 24 months post
baseline (whole cohort)
 proportions of children classified as overweight
or obese [11]
 waist circumference SDS [12]
 percent body fat SDS [13]
2. Objectively measured physical activity measures at
18 months post baseline (subset of one randomly
selected class per school; approximately 67% of
whole cohort) [14]
 mean daily time spent sedentary
 mean daily time spent in light physical activity
 mean daily time spent in moderate physical
activity
 mean daily time spent in vigorous physical
activity
 mean daily time spent in moderate/vigorous
physical activity (MVPA)
 mean milli-gravity value (a measure of the aver-
age acceleration for each child across the whole
observation period)
3. Self-reported food intake at 18 months post baseline
(whole cohort) [15]
 mean number of healthy snacks consumed
per day
 mean number of energy dense snacks consumed
per day
 mean number of positive foods markers
consumed per day
 mean number of negative foods markers
consumed per day
All the above measures were also captured at baseline.
General analyses principles
Participant population
The analysis population will consist of all randomised
children excluding: (1) children who left the trial geo-
graphical area prior to the collection of baseline mea-
sures and (2) withdrawn children who were unwilling
for collected data to continue to be used.
The primary analysis for each outcome will be under-
taken on an ‘intention-to-treat’ (ITT) basis, i.e. all
children with a recorded outcome will be included in
the analysis and will be analysed according to the group
to which they were allocated [16]. Whilst it is not antici-
pated that there will be many children who cross-over
their trial group (i.e. change from intervention to con-
trol, or vice versa), any instances will be documented.
The full analysis population for the primary outcome
analysis will consist of all randomised children for whom
baseline anthropometric data were collected and for
whom 24-month anthropometric data are available. If a
child moves to another school within the trial geograph-
ical area after baseline measure were collected, they will
be invited to continue with the data collection over the
remaining period of the trial. As the full analysis
population in the primary analysis will exclude a
small number of children lost to follow-up (i.e. for
whom 24-month BMI data is not available), a sensi-
tivity analysis will be performed to account for all
randomised children (see below).
Levels of confidence and p values
Statistical tests and confidence intervals will be two-
sided. Between-group comparisons will be calculated
and presented with 95% confidence intervals wherever
possible. The statistical significance level set will be at
the 5% level.
Unadjusted and adjusted analyses
All comparative analyses will allow for the clustered na-
ture of the data to ensure correct confidence intervals
and type I error rates are calculated [17, 18]. As the trial
includes a reasonable number of clusters (i.e. 32
schools), the analyses will be based on the individual
child-level data, allowing for the clustering between chil-
dren within the same school, rather than on the cluster-
level summarised data, which is appropriate when only a
small number of clusters are present [17, 18]. For each
outcome, unless otherwise specified, the primary analysis
will be the covariate-adjusted analysis, with the statistical
models including the two stratification variables
(proportion of children eligible for free school meals
and number of year-5 classes), cohort, gender and
baseline values for the outcome under consideration,
where available. Unadjusted between-group differ-
ences will be presented for completeness [19].
Multiple testing
Adjustments will not be made for multiple tests under-
taken as the primary outcome of interest is clearly de-
fined. As this is a trial of a complex intervention the
secondary outcomes are all potentially of interest and
relevance to participants, parents and other stakeholders.
Interpretation of the clinical significance of any differ-
ences between the two groups will acknowledge the
range of variables being measured.
Creanor et al. Trials  (2016) 17:599 Page 4 of 9
Missing data
In the event that a child is not available for the collec-
tion of outcome measures, up to three additional school
visits are organised to try to capture the missing mea-
sures. However, even with these additional visits, some
loss to follow-up is expected over 24 months. The pro-
portion of children missing each outcome will be sum-
marised for each allocated group and at each time point,
with reasons for missing outcomes documented wher-
ever possible. The main analysis of the primary outcome
uses the BMI data at 24 months which could be missing
for a number of reasons:
1. Parent/carer opts child out of trial before follow-up
data collection
2. Child refused to participate in collection of the
weight measurement using the Tanita scales
3. Child moved out of the trial geographical area
before follow-up data collection
4. Child absent on day of measurement and
subsequent follow-up visits
5. Child withdrew from the study
There is no a priori reason to assume that children
who are lost to follow-up are missing not at random.
Therefore, for the primary analysis, no imputation of
missing anthropometric data will be undertaken and this
primary outcome analysis will be based on the complete
case/observed outcomes dataset [16]. A sensitivity ana-
lysis of the primary outcome will account for all children
randomised (see below), with missing BMI SDS mea-
sures imputed.
In terms of the secondary outcomes, to be included in
the physical activity analysis children need to comply
with the required minimum continuous wear time of at
least 10 h a day for three weekdays and one weekend
day. Non-wear will be determined using a published al-
gorithm, details of which can be found elsewhere [20].
In participants who meet the minimum wear time cri-
teria, the data will again be passed over in 60-min rolling
windows with 45-min overlap to identify 15-min blocks
of non-wear. The 15-min blocks will then imputed based
on the average movement recorded in 15-min blocks at the
same time of day for the whole monitoring [21]. Any time
window with more than 50% non-wear will be treated as
missing. For the food intake questionnaire, where a child is
missing a subset of the items, the total score will be extrap-
olated based on the average scores across the four categor-
ies (Energy Dense Snacks, Health Snack foods, Negative
Food Markers, Positive Food Markers) [4, 15].
Presentation of comparative analyses
For each of the continuous outcomes (including the pri-
mary outcome), the mean and standard deviation for
each allocated group will be presented, together with the
mean between-group difference, 95% confidence interval
for the difference and p value. For binary outcomes, the
percentage and frequency of children in the outcome
category of interest (e.g. percentage overweight/obese)
will be presented for each allocated group, along with
the odds ratio for the intervention effect, 95% confidence
interval for the odds ratio and p value. Similarly, for
ordinal outcomes, the percentage and frequency of
children in each outcome category will be reported for
each allocated group, along with the odds ratios, 95%
confidence intervals for the odds ratios and p value. In
addition, the intracluster correlation coefficient will be
reported for each outcome, based on the adjusted ana-
lyses, together with 95% confidence interval.
Proposed analyses
Baseline
Participating schools will be compared to state primary
schools in Devon and England at the time of school re-
cruitment into the trial (2012) in terms of (1) percentage
of children eligible for free school meals, (2) number of
year-5 classes/school size, (3) percentage of children
achieving level 4 at Key Stage 2, (4) percentage of pupils
with English as an additional language or who are non-
white British.
Baseline characteristics, collected at the time of com-
mencing the trial, will be cross-tabulated according to
the randomised group to check for appropriate balance
and to provide an overview of the study population, both
at the school and child levels. At the school level, this
will include the percentage of children eligible for free
school meals, index of multiple deprivation score for the
school’s postcode, number of year-5 classes, and percent-
age of pupils for whom English is an additional language.
At the child level, variables will include gender, age at
baseline data collection, individual Index of Multiple
Deprivation (IMD) values, baseline measures of all an-
thropometric measurements, physical activity and food
intake. The baseline characteristics of each group will be
summarised as the mean, standard deviation and range
for continuous, approximately symmetric variables; me-
dians, interquartile range and range for continuous, skewed
variables; frequencies and percentages of children/schools
in each category for categorical variables.
It is expected that children in both allocated groups
will, on average, be similar, given the randomisation pro-
cedure. The formal statistical comparison at baseline of
randomised groups is not good practice [22] and thus
will not be undertaken – only descriptive data, as de-
scribed above, will be presented. If substantial baseline
imbalance between randomised groups is identified in
terms of any relevant variables not already being ad-
justed for in the primary analysis, additional adjusted
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sensitivity analyses may be performed, to allow for such
variable(s), in addition to the prespecified variables for
adjustment, to assess the robustness of the primary ana-
lysis [19, 22].
Primary analysis of primary outcome
As described above, the primary analysis of the primary
outcome, BMI SDS at 24 months, will follow an
intention-to-treat approach, with children analysed ac-
cording to the trial group to which their school was
randomised. Comparisons between the two groups will
be implemented using random effects regression, allow-
ing for the clustered nature of the data, and adjusted
using the covariates specified above (see ‘Unadjusted
and adjusted analyses’ section above).
Planned and updated sensitivity analyses of primary
outcome
A sensitivity analysis will be undertaken after imputing
the missing BMI scores, to account for all randomised
children. Originally it was anticipated that multiple
imputation would be used to impute the missing BMI
scores based on the assumption of missing at random.
The imputation model was planned to include BMI SDS,
gender, cohort and school and any other variables
potentially related to missingness, with the imputations
performed separately for each allocated group.
During the collection of the final 24-month measures,
it was clear that the follow-up rate was very high. After
final data cleaning and database lock, we were able to
report to our trial management group and TSC that at
24 months we had primary outcome data for 94.4%
(1250/1324) of recruited children and 94.8% (1244/1312)
of children with baseline BMI SDS. Whilst two thirds of
the children with no primary outcome data had moved
schools outwith the geographical area, the missing-at-
random assumption was less plausible for some of the
other children missing at 24 months. Following detailed
discussions with our TSC in July 2016, it was agreed that
the planned multiple imputation should be replaced by a
‘best case/worst case’ sensitivity analysis. The first of
these is based on hypothetically driven assumptions,
given the hypothetical preventative nature of the HeLP
intervention.
The ‘best’ case scenario will:
(a) assume no change between baseline and 24 months
in BMI SDS for children allocated to the
intervention group, i.e. the baseline BMI SDS value
will be carried forward to replace the missing
24-month BMI SDS value
(b) impute missing 24-month BMI SDS values for
children allocated to the control group with their
corresponding baseline BMI SDS value plus the
(marginal) mean change between baseline and
24 months for the children allocated to the control
group with complete baseline and 24-month BMI
SDS data.
The ‘worst’ case scenario will:
(a) assume that children allocated to the intervention
group who were not obese at baseline were obese
at the 24-month follow-up: the 24-month BMI SDS
value will be set at the Public Health England
threshold for obesity (i.e. the 95th percentile; this is
1.645). For children allocated to the intervention
group who were obese at baseline, the baseline BMI
SDS value will be carried forward to replace the
missing BMI SDS value
(b) impute missing 24-month BMI SDS values for
children allocated to the control group with their
corresponding baseline BMI SDS value plus the
(marginal) mean change between baseline and
24 months for the children allocated to the control
group with complete baseline and 24-month BMI
SDS data
After imputing the missing 24-month BMI SDS
scores for both scenarios, the primary analyses model
will then be fitted to the full intention-to-treat data-
sets to ascertain whether the missing primary out-
come data significantly influenced the results of the
primary effectiveness analysis.
We anticipate that there will have been only a small
number of children who will have ‘switched’ between
allocated treatment groups, and hence a ‘per-protocol’
analysis of actual treatment received is not likely to be
informative. However, the primary analysis intention-to-
treat strategy, whilst providing an unbiased estimate of
the effect of randomising to intervention or control
groups, may underestimate the effect of actually receiv-
ing HeLP. Therefore, further exploratory analyses of the
primary outcome are planned to estimate the complier
average causal effect of treatment (CACE), as a poten-
tially unbiased estimate of receiving HeLP [23]. Com-
pliers can only be observed amongst those randomised
to receive HeLP and will be defined as those children
who received more than four sessions of drama activities
during healthy lifestyles week and who participated in 1:
1 goal setting in phase 3; an indicator variable will be
created to identify whether each child randomised to the
intervention group complied or not. If there are suffi-
cient numbers within the two categories, compliers
and noncompliers within the intervention group will
be compared in terms of key baseline characteristics
and the estimated CACE between-group difference
will be obtained using instrumental variable regression
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including the same covariates used in the primary
analysis, together with randomised group as an in-
strumental variable for treatment received and includ-
ing the indicator variable for compliance [23].
Subgroup analyses of primary outcome
Exploratory analyses of the following possible interac-
tions will be undertaken to assess whether the effect of
the HeLP intervention is modified by (1) gender, (2)
baseline BMI SDS, (3) number of year-5 classes within
school and (4) socioeconomic status. These subgroup
analyses will be performed by adding the interaction
term between allocated group and the subgroup variable
into the regression model. A test of interaction will also
be performed to assess whether there is evidence that
the effect of the intervention differs across the two co-
horts. As the study is not powered for these interaction
analyses the results will be treated with caution [24];
given the exploratory nature of these investigations,
the emphasis will be on the interpretation of the cor-
responding confidence intervals for such subgroups.
In addition to these subgroup analyses, there is a
planned mediational analysis as part of the process
evaluation, which will include both moderator and
mediator variables.
Analysis of secondary outcomes
Secondary outcomes will be compared between groups
based on the complete data only. Most of the secondary
outcomes are of a continuous nature and so comparative
analyses will follow the approach detailed above for the
primary outcome, using random effects regression,
allowing for the clustered nature of the data and includ-
ing the stratification factors, baseline value of the vari-
able under consideration and gender and cohort. Binary
outcomes (such as the proportion of children classified
as overweight/obese at 24 months) will be analysed
using binary logistic regression, allowing for the clus-
tered nature of the data, and including the stratification
factors, baseline BMI SDS, gender and cohort. Ordinal
outcomes, e.g. categorisation of weight status, will be
similarly analysed using ordinal logistic regression. For
all models, corresponding distributional assumptions
will be investigated, with consideration given to provid-
ing boot-strapped confidence intervals for estimates of
between-group differences.
Longitudinal analysis of anthropometric outcomes
A repeated measures mixed-effects model will also be
fitted to all the observed anthropometric measures at
baseline, 18 months and 24 months, including effects of
time and the interaction term between allocated group
and time, to assess whether there is evidence that the ef-
fect of the intervention differs across time, taking into
account the correlation between measures from the
same child, whilst also allowing for the clustered trial
design.
Adverse events
Numbers and percentages of adverse events and serious
adverse events will be cross-tabulated with allocated
group and also by the actual group, to account for any
children who ‘switched’ between intervention and con-
trol schools. If there are sufficient numbers of adverse
events, binary logistic regression will be used to estimate
the odds ratio for the group effect, together with the
corresponding 95% confidence interval and p value.
Discussion
The article reporting the protocol for this cluster rando-
mised trial was submitted in May 2012, prior to schools
and children being recruited. That article included a
brief outline of the planned statistical analyses, which
were subsequently further developed after the start of
the trial. This detailed statistical analysis plan was writ-
ten during the delivery period of the HeLP trial (Septem-
ber 2012 to December 2015) and was approved and
signed off by the HeLP TSC in October 2015 prior to
final data collection. A minor amendment to the
planned sensitivity analyses was made following the
meeting of the TSC in July 2016, with the amendment
approved by the TSC in September 2016, prior to any
sensitivity analyses being undertaken. The full analysis
plan (including details of the planned mediational ana-
lyses and outline of the economic evaluation) is linked
to the trial protocol on the NIHR website (www.nets.
nihr.ac.uk/projects/phr/10301001).
The rise in the frequency of prospectively publishing
statistical analysis plans has followed on from the in-
creasing numbers of trial protocols being published in
peer-reviewed journals. In February 2016, a PubMed
search with ‘statistical analysis plan’ in the title identified
53 references: the first two statistical analysis plan
articles being published in 2009 [25, 26], rising to 15
such papers in 2013 and 2014, with only a small drop to
13 published statistical analysis plan papers in 2015.
However, only three of these articles reported on the
analysis plan of a cluster randomised trial [27–29], with
one reporting analysis plans for a feasibility study, thus
analyses of a different nature. The increasing frequency
of publishing both trial protocols and statistical analysis
plans has been led by a move to increase transparency
and ensure that trial outcomes are not selectively re-
ported. The recently established COMPARE (‘tracking
switched outcomes in clinical trials’) project assesses the
proportion of prespecified outcomes for a trial which are
subsequently reported in the associated trial results paper,
together with the number of undeclared, not prespecified
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outcomes reported [30]. The COMPARE team writes to
journal editors with notification not only of discrepancies
between prespecified and reported outcomes, but also when
trial papers include nonprespecified analytic approaches.
By placing statistical analysis plans in the public do-
main, prior to final database lock, researchers can ensure
that the analyses reported in subsequent results papers
were prespecified, particularly with regards to secondary
analyses, and not data-driven. This is particularly
relevant in instances where there are a number of
different statistical methods to analyse an outcome.
Whilst it is hoped that results would be robust and give
similar conclusions, regardless of the method selected,
by prespecifying the method(s) of analysis, trialists are
prevented from employing different methods of analysis
and then reporting only the method which gave the
most favourable results.
Finally, we hope that by publishing our detailed statis-
tical analysis plan for a cluster randomised trial of a
complex intervention, it may be of use to other teams
developing plans for trials of a similar design [31],
particularly given that, to date, the vast majority of
published articles reporting statistical analysis papers
are for hospital-based trials, mainly of medicinal
products or devices.
Trial status
Recruitment of all schools was completed in June 2012,
recruitment of all children was completed by September
2013 and the final 24-month follow-up outcomes were
collected in December 2015. Final data entry and clean-
ing is currently underway (February 2016), with final
database lock anticipated at the end of February 2016,
with the statistical analyses due to commence on time in
April 2016. Since submission of the initial version of this
paper (February 2016), a minor amendment has been
made to the planned sensitivity analyses based on the
completeness of the primary outcome data, as reported
in the final version of this paper. It is expected that final
results will be available in autumn 2016.
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